<?xml version="1.0" encoding="UTF-8"?>
<p>In the non-diabetic subgroup, the number of subjects with fatty liver decreased from 231 to 124 subjects (−46.3%), while the number of subjects with normal FLI (&lt;30 points) increased from 273 to 395 subjects (+44.7%). In the T2DM subgroup, the number of patients with fatty liver decreased from 33 to 21 (−36.4%), while the number of patients with normal FLI increased from 1 to 4. An absolute FLI reduction of &gt;30% was achieved in 60.9% of all subjects who had a weight reduction of ≥5% from baseline.</p>
